| Hussein Hussein, | |
|
224 W Exchange St, Akron, OH 44302-1704 | |
| (330) 344-6676 | |
| Not Available |
| Full Name | Hussein Hussein |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 17 Years |
| Location | 224 W Exchange St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205144045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 35.130654 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Akron General Medical Center | Akron, OH | Hospital |
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
On Thursday, May 20, 2010, the U.S. House of Representatives Committee on Education and Labor held a hearing to learn more about the impact of concussions on high school athletes and how the injury can impact academic achievement. A concussion is an injury to the brain that results in loss of normal brain function and is usually temporary.
Minutes after President Obama signed his health-care program into law on March 23, 2010, Virginia Attorney General Ken Cuccinelli II raced to become the first state official to challenge it in court. But as a federal appeals court panel concluded Thursday, being first isn't the same as being right. ... Even if timing were not an issue, the notion that a state could nullify a federal program in this way is absurd (9/8).
As the Western European multiparameter patient monitor (MPM) market is in its mature stage, it will generate most of its revenues from replacement units. On the other hand, the Eastern European market, which has not reached maturity, will predominantly see new MPM installations.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
Johns Hopkins engineers have invented a lab device to give cancer researchers an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90 percent of cancer-related deaths. By shedding light on precisely how tumor cells travel, the device could uncover new ways to keep cancer in check.
› Verified 4 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
On Thursday, May 20, 2010, the U.S. House of Representatives Committee on Education and Labor held a hearing to learn more about the impact of concussions on high school athletes and how the injury can impact academic achievement. A concussion is an injury to the brain that results in loss of normal brain function and is usually temporary.
Minutes after President Obama signed his health-care program into law on March 23, 2010, Virginia Attorney General Ken Cuccinelli II raced to become the first state official to challenge it in court. But as a federal appeals court panel concluded Thursday, being first isn't the same as being right. ... Even if timing were not an issue, the notion that a state could nullify a federal program in this way is absurd (9/8).
As the Western European multiparameter patient monitor (MPM) market is in its mature stage, it will generate most of its revenues from replacement units. On the other hand, the Eastern European market, which has not reached maturity, will predominantly see new MPM installations.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
Johns Hopkins engineers have invented a lab device to give cancer researchers an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90 percent of cancer-related deaths. By shedding light on precisely how tumor cells travel, the device could uncover new ways to keep cancer in check.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hussein Hussein, 5115 Duxbury Dr, Copley, OH 44321-1007 Ph: (203) 809-8425 | Hussein Hussein, 224 W Exchange St, Akron, OH 44302-1704 Ph: (330) 344-6676 |
News Archive
On Thursday, May 20, 2010, the U.S. House of Representatives Committee on Education and Labor held a hearing to learn more about the impact of concussions on high school athletes and how the injury can impact academic achievement. A concussion is an injury to the brain that results in loss of normal brain function and is usually temporary.
Minutes after President Obama signed his health-care program into law on March 23, 2010, Virginia Attorney General Ken Cuccinelli II raced to become the first state official to challenge it in court. But as a federal appeals court panel concluded Thursday, being first isn't the same as being right. ... Even if timing were not an issue, the notion that a state could nullify a federal program in this way is absurd (9/8).
As the Western European multiparameter patient monitor (MPM) market is in its mature stage, it will generate most of its revenues from replacement units. On the other hand, the Eastern European market, which has not reached maturity, will predominantly see new MPM installations.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
Johns Hopkins engineers have invented a lab device to give cancer researchers an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90 percent of cancer-related deaths. By shedding light on precisely how tumor cells travel, the device could uncover new ways to keep cancer in check.
› Verified 4 days ago
Dr. Michael A Pelini, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Ste 300, Akron, OH 44304 Phone: 330-376-7000 Fax: 330-376-1066 | |
David P. Lang, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #200c, Akron, OH 44333 Phone: 330-665-8031 Fax: 330-665-8360 | |
Ms. Tiffany Mccann, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3561 | |
Jonathan Buggey, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St Ste 300, Akron, OH 44304 Phone: 724-422-6808 | |
Shamsa Baaj, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Mira Rohit Patel, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 161 N Forge St Ste 198, Akron, OH 44304 Phone: 330-375-3039 | |
Richard J Streck, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, 5th Floor Ambulatory Care Center, Akron, OH 44307 Phone: 330-344-6015 Fax: 330-344-6820 |